0001104659-20-106765.txt : 20200921
0001104659-20-106765.hdr.sgml : 20200921
20200921081115
ACCESSION NUMBER: 0001104659-20-106765
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200917
FILED AS OF DATE: 20200921
DATE AS OF CHANGE: 20200921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Clauser Noah
CENTRAL INDEX KEY: 0001796466
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37467
FILM NUMBER: 201185232
MAIL ADDRESS:
STREET 1: 100 HIGH STREET
STREET 2: 28TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATABASIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001454789
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 1400E, SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-349-1971
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 1400E, SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
a4.xml
4
X0306
4
2020-09-17
0
0001454789
CATABASIS PHARMACEUTICALS INC
CATB
0001796466
Clauser Noah
C/O CATABASIS PHARMACEUTICALS, INC.,
100 HIGH STREET, FLOOR 28
BOSTON
MA
02110
0
1
0
0
Chief Financial Officer
Stock Option (right to buy)
6.94
2020-09-17
4
A
0
35000
0
A
2030-09-16
Common Stock
35000
35000
D
This option was granted on September 17, 2020 and is subject to vesting over a four year period with 25% of the shares vesting on the first anniversary of September 17, 2020 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.
/s/ Noah Clauser
2020-09-21